The Bottom Fishing Club - Baxter: Defensive Pick, Restructuring And Paying Down Debt

Baxter trades at low valuations with 8x forward cash earnings, debt reduction, cost controls, margin expansion, and $50 2027 ...

NYC public school hosts Mamdani’s political pick, flouting policy

DIANA DEMERIT: Mayor Zohran Mamdani’s preferred candidate to fill his former state Assembly seat made a campaign stop in a ...

AbbVie Announces Topline Results for Epcoritamab (DuoBody CD3xCD20) from Phase 3 EPCORE DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Based on the topline results from the EPCORE® DLBCL-1 trial, AbbVie along with partner Genmab will engage global regulatory authorities to discuss next steps NORTH ...
Philomath News

Three Things: PHS ranks No. 12 statewide, grocery store challenges, beaver solution at Bald Hill

Philomath High ranks No. 12 statewide, Mayor McMorran addresses grocery store obstacles through zoning updates, and beavers prompt innovative fence solution at Bald Hill Farm.

Raptors waste positive performances, blow game against Kawhi-less Clippers

No Kawhi Leonard, no problem for the Los Angeles Clippers. At least for one night.

Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, which ...